Select a year:

4P-Pharma will attend the 17th annual BIO-Europe Spring

4P-Pharma will attend the 17th annual BIO-Europe Spring on March 20–22, 2023, in Basel, Switzerland. Our Chief Development Officer, Frédéric Marin and our Business Development & Licensing-in Manager, Roselina Lam will be participating in this European biotechs and Pharma’s large spring event. Feel free to contact us, to make an appointment, to discuss partnering or&hellip

Read More

4P-Pharma is attending JP Morgan Week 2023

We are pleased to attend JPM Week 2023 from January 9th to 11th in California, United States. Our CEO Revital Rattenbach is looking forward to seeing you in person at this significant networking event for our healthcare ecosystem. Meet her at the French Healthcare Corner during JPM week 2023.

Read More

Discover 4P-Pharma’s clinical vision

4P-Pharma is thrilled to share the last video of company portrait galleries realized in collaboration with the magazine Entreprendre to highlight our innovative company activities and story. This video focuses on our clinical vision, aiming to rapidly deliver effective, regenerated, first-in-class therapies for untreated serious diseases with high unmet medical needs. 4P-Pharma has developed a&hellip

Read More

Discover our second video focus on our preclinical department

4P-Pharma is pleased to share the second video of a series of three videos made in collaboration with Entreprendre magazine in order to highlight innovative biotechnology companies. In this second video, we spotlight our company preclinical vision. Driven by the vision of combining the biology of untreated diseases with the mechanism of action of drugs, we&hellip

Read More

Have a look at our first series of three company videos

4P-Pharma is pleased to share with you a series of three videos produced in collaboration with Entreprendre magazine in order to highlight innovative biotechnology companies. This series of three videos opens the doors of our company which is dedicated to the regeneration of active drugs in order to develop first class therapies to cure untreated&hellip

Read More